Immunogenicity and Safety of 1 vs 2 Doses of Quadrivalent Meningococcal Conjugate Vaccine in Youth Infected With Human Immunodeficiency Virus

Journal of Pediatrics - United States
doi 10.1016/j.jpeds.2012.04.005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Immunogenicity and Safety of a Booster Dose of a Quadrivalent Meningococcal Tetanus Toxoid-Conjugate Vaccine (MenACYW-TT) in Adolescents and Adults: A Phase III Randomized Study

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2020English

Safety and Pharmacokinetics of Abacavir (1592U89) Following Oral Administration of Escalating Single Doses in Human Immunodeficiency Virus Type 1-Infected Adults

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1999English

Safety and Immunogenicity of Haemophilus Influenzae Type B Conjugate Vaccine in Copd

Journal of Evolution of Medical and Dental Sciences
2016English

Induction of Neutralizing Antibodies Against Tier 2 Human Immunodeficiency Virus 1 in Rhesus Macaques Infected With Tier 1B Simian/Human Immunodeficiency Virus

Archives of Virology
MedicineVirology
2019English

Immunogenicity and Safety of 7-Valent Pneumococcal-Crm197 Conjugate Vaccine. ▴ 1082

Pediatric Research
Child HealthPediatricsPerinatology
1996English

Biomarkers of Vascular Dysfunction in Children Infected With Human Immunodeficiency Virus-1

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2010English

Factors Contributing to the Immunogenicity of Meningococcal Conjugate Vaccines

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2016English

Antibody Persistence Up to 5 Y After Vaccination With a Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine in Adolescents

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2017English

Advice for Consideration of Quadrivalent (A, C, Y, W135) Meningococcal Conjugate Vaccine, for Use by Provinces and Territories

Canada Communicable Disease Report
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy